Jove
Visualize
Contact Us

Related Experiment Videos

Tools for target identification and validation.

Shenliang Wang1, Tae Bo Sim, Yang-Suk Kim

  • 1Department of Chemistry, New York University, New York, NY 10003, USA.

Current Opinion in Chemical Biology
|August 4, 2004
PubMed
Summary

Advanced technologies like microarrays, bioinformatics, and antisense technologies are crucial for identifying and validating drug targets. These methods accelerate drug development by providing gene expression data and functional insights.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visualizing Biomolecules within Living Microglia in Complex Environments Using a Clickable Small Fluorogenic Compound.

ACS chemical neuroscience·2026
Same author

Mechanism elucidation of cell-selective fluorescent probes.

Smart molecules : open access·2026
Same author

Channelopathies (Olmsted Syndrome)-causing point mutations of TRPV3 disrupt cellular thermal homeostasis in human keratinocytes.

Life sciences·2026
Same author

Bmal1 regulates thermogenic function by modulation of lipolytic and oxidative phosphorylation gene expression in male mice brown adipocytes.

Endocrinology·2026
Same author

Dual binding and efflux mechanisms involving HMOX2 and ABCB1 regulate the tumor selectivity of a near-infrared theranostic probe.

International journal of biological macromolecules·2026
Same author

Alteration of metabolic activity regulates mitochondrial temperature in diagnosis in HepG2 hepatocellular carcinoma cells.

Scientific reports·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Genomics
  • Proteomics
  • Drug Development
  • Bioinformatics

Background:

  • Reliable target identification and validation are fundamental to successful drug development.
  • Microarrays are widely used in genomics and proteomics for gene/protein expression profiling and target validation.
  • Bioinformatics plays a key role in analyzing high-throughput data and providing functional and network information for target candidates.

Purpose of the Study:

  • To review and highlight key technologies for target identification and validation in drug development.
  • To discuss the contributions of various approaches including microarrays, bioinformatics, and newer techniques.

Main Methods:

  • Gene and protein expression profiling using microarrays.

Related Experiment Videos

  • Bioinformatic analysis for functional and network information.
  • Gene knockdown using antisense technologies (e.g., RNA interference).
  • DNA transcription targeting with zinc finger proteins.
  • Phenotype generation via chemical genomics and proteomics.
  • High-throughput screening using NMR-based screening and activity-based protein profiling.

    • Main Results:

    • Microarrays provide essential data for gene/protein expression and target validation.
    • Bioinformatics enhances target identification by offering functional insights and network positioning.
    • Antisense technologies enable sequence-specific gene knockdown at the RNA level.
    • Emerging tools like chemical genomics, proteomics, NMR screening, and activity-based protein profiling are advancing high-throughput target identification.

    Conclusions:

    • A diverse array of technologies, from established methods like microarrays to emerging techniques, are vital for efficient drug target identification and validation.
    • The integration of genomics, proteomics, bioinformatics, and advanced screening methods is critical for accelerating the drug discovery pipeline.